Hemophilia as a blueprint for gene therapy

被引：13
|
作者：
Ragni, Margaret V. [1 ,2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
[2] Hemophilia Ctr Western, Pittsburgh, PA 15213 USA
来源：
SCIENCE | 2021年 / 374卷 / 6563期
基金：
美国国家卫生研究院;
关键词：
EMICIZUMAB;
D O I：
10.1126/science.abg0856
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Advances in hemophilia gene therapy could enable progress in other inherited disorders
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [31] Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor
    Nakajima, Yuto
    Tonegawa, Hitoshi
    Noguchi-Sasaki, Mariko
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) : 789 - 796
  • [32] Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor
    Yuto Nakajima
    Hitoshi Tonegawa
    Mariko Noguchi-Sasaki
    Keiji Nogami
    International Journal of Hematology, 2021, 113 : 789 - 796
  • [33] Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors
    Carcao, Manuel
    Mancuso, Maria Elisa
    Young, Guy
    Jimenez-Yuste, Victor
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (02) : 143 - 148
  • [34] Immunogenicity of Current and New Therapies for Hemophilia A
    Prezotti, Alessandra N. L.
    Frade-Guanaes, Jessica O.
    Yamaguti-Hayakawa, Gabriela G.
    Ozelo, Margareth C.
    PHARMACEUTICALS, 2022, 15 (08)
  • [35] Evaluating the safety of emicizumab in patients with hemophilia A
    Langer, Arielle L.
    Etra, Aaron
    Aledort, Louis
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1233 - 1237
  • [36] Clinical pharmacology of emicizumab for the treatment of hemophilia A
    Yoneyama, Koichiro
    Schmitt, Christophe
    Portron, Agnes
    Kiialainen, Anna
    Kotani, Naoki
    Jaminion, Felix
    Retout, Sylvie
    Adamkewicz, Joanne, I
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, : 775 - 790
  • [37] The availability of new drugs for hemophilia treatment
    Morfini, Massimo
    Marchesini, Emanuela
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (07) : 721 - 737
  • [38] Orthopedic surgical procedures in people with hemophilia
    Encinas-Ullan, Carlos A.
    De la Corte-Rodriguez, Hortensia
    Gomez-Cardero, Primitivo
    Rodriguez-Merchan, E. Carlos
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 : S5 - S8
  • [39] Inhibitor eradication and treatment for acquired hemophilia A
    Franchini, Massimo
    Focosi, Daniele
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 233 - 240
  • [40] The evolution of recombinant factor replacement for hemophilia
    Sankar, Amanda D.
    Weyand, Angela C.
    Pipe, Steven W.
    TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (05) : 596 - 600
12345